{"id":16932,"date":"2020-10-09T07:27:47","date_gmt":"2020-10-09T11:27:47","guid":{"rendered":"https:\/\/medicarereport.org\/?p=16932"},"modified":"2020-10-09T07:27:47","modified_gmt":"2020-10-09T11:27:47","slug":"high-quality-care-for-medicare-beneficiaries-continues-as-medicare-health-and-drug-plans-receive-star-ratings","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=16932","title":{"rendered":"High-Quality Care for Medicare Beneficiaries Continues as Medicare Health and Drug Plans Receive Star Ratings"},"content":{"rendered":"

(Source – www.cms.gov\/newsroom)<\/p>\n

The Centers for Medicare & Medicaid Services (CMS) announced that Medicare beneficiaries will continue to have access to high-quality Medicare Advantage and Part D prescription drug plans in 2021. According to the latest data, quality ratings of Medicare Advantage and Medicare Part D drug plans remain strong. Most Medicare beneficiaries \u2013 about 77 percent \u2013 who enroll in Medicare Advantage plans with drug coverage will be in plans with four or more stars in 2021. That compares with 69 percent of beneficiaries enrolled in such plans in 2017. Almost half \u2013 about 49 percent \u2013 of Medicare Advantage plans that offer prescription drug coverage will have an overall rating of four stars or higher, up from about 45 percent in 2017. The average Star Rating for all Medicare Advantage plans with prescription drug coverage improved to 4.06 out of 5 stars in 2021 from 4.02 in 2017.\u00a0 Continue reading news release here…<\/a><\/p>\n

\"\"<\/a><\/p>\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"
(Source – www.cms.gov\/newsroom) The Centers for Medicare & Medicaid Services (CMS) announced that Medicare beneficiaries will continue to have access<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,9,15],"tags":[],"class_list":["post-16932","post","type-post","status-publish","format-standard","hentry","category-cms","category-medicare-advantage","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16932"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16932\/revisions"}],"predecessor-version":[{"id":16933,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/16932\/revisions\/16933"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}